Based in Utah, the Global Organization of EPA and DHA Omega-3 (GOED Omega-3) said it is committed to "developing EPA and DHA omega-3 consumer awareness and education strategies, and implementing quality standards and other measures that will continue to increase consumer confidence in the omega-3 EPA/DHA category."
Essentially, this means informing consumers of how the bioactives EPA (eicosa-pentaenoic acid) and DHA (docosahexaenoic acid) have greater bioactive potential in the body than other sources of omega-3s such as ALA (alpha-linolenic acid) — which the body inefficiently converts to EPA/DHA and which of itself has few health benefits other than its fibre content. The group, whose members pay $12,000 a year, is establishing a website to assist this goal, as well as a monthly newsletter.
New product development (NPD), establishing official maximum levels and other regulatory approvals such as health claims are also high on the group's agenda, said GOED Omega-3 vice chairman, Thomas Grys, who is the managing director of Norwegian supplier, Denomega.
"We are in the process of establishing a research foundation that will assist in these activities to carry out research, develop health claims, formulation and NPD," he told FF&N. "We are also looking into the best ways to communicate omega-3 content to consumers on-pack, whether that be as a percentage of an established daily intake or in grams, as it is most commonly done at the moment. We are also looking at having a GOED logo to put on products."
GOED Omega-3 would also take up political positions where necessary, and is in the process of developing a response to the European Union health-claims initiative as FF&N went to press, Grys said.
Members include Ocean Nutrition Canada, DSM, Lonza, Croda, Lipid Nutrition, Nu-Mega and Martek.